Nuvolo Technologies raises $2 mln

By Luisa Beltran — 3 months ago

Nuvolo Technologies said Wednesday that it secured $2 million in seed funding from New Enterprise Associates and ServiceNow. New York-based Nuvolo develops enterprise applications on the ServiceNow platform.

Continue

Tamr raises $25.2 mln in Series B funding

By Chris Witkowsky — 8 months ago

Data analytics business Tamr, Inc. raised $25.2 million in Series B funding from Hewlett-Packard Ventures, Thomson Reuters, MassMutual Ventures, the corporate venture arm of Massachusetts Mutual Life Insurance Company, Sinewave Ventures and Work-Bench Ventures. Existing investors New Enterprise Associates and Google Ventures also participated in the funding round.

Continue

Dermira fetches $51 mln Series C

By Iris Dorbian — 1 year ago

Dermira, a Redwood City, Calif-based maker of medical dermatology products, has closed $51 million in Series C financing. The investors included Bay City Capital, New Enterprise Associates, Canaan Partners, UCB S.A., Apple Tree Partners, Aisling Capital, Rock Springs Capital and Sabby Capital. Leerink Partners was the placement agent for the financing. In addition to the funding, Dermira has named Andrew Guggenhime as chief operating officer and chief financial officer; Christine Conroy as senior vice president of regulatory affairs; and Christine Ring as vice president of legal. It has also appointed David E. Cohen, Matthew Fust, Mark McDade and William Ringo to its board of directors.

Continue

Curalate inks $8.6 mln Series B led by NEA

By Angela Sormani — 2 years ago

Curalate has secured $8.6 million in Series B financing, bringing total funding to $12.5 million. NEA led the round with participation from First Round Capital, MentorTech Ventures and Vayner RSE, Gary Vaynerchuck’s new $25 million fund. Curalate is a visual analytics and marketing platform.

Continue

Actor Dempsey invests in VC-backed CrowdMed

By Iris Dorbian — 2 years ago

San Francisco-based healthcare startup CrowdMed said Tuesday that it has received an undisclosed investment from actor Patrick Dempsey. CrowdMed is backed by NEA, Andreessen Horowitz, Greylock Partners, SV Angel, Khosla Ventures and Y Combinator.

Continue

Quad Learning garners $10 mln

By Iris Dorbian — 2 years ago

Quad Learning said Tuesday that it has secured $10 million in Series B funding. The investors included MentorTech Ventures, ECMC Group, SWaN & Legend Fund, New Atlantic Ventures, CNF Investments, New Enterprise Associates and Comcast Ventures. In addition to the funding, Joe Del Guercio of CNF Investments has been added to Quad Learning’s board. Based in Washington, D.C., Quad Learning works with community colleges to offer honors programs to students.

Continue

VC-backed Opower rolls out IPO

By Iris Dorbian — 2 years ago

Opower has priced its IPO of 6.1 million shares at $19 per share. The stock began trading Friday on the NYSE under the ticker symbol “OPWR.” Morgan Stanley & Co. and Goldman Sachs are the lead underwriters. Headquartered in Arlington, Virginia, Opower is a provider of cloud solutions for the utility sector. Its backers include New Cycle Capital, NEA, Accel Partners and Kleiner Perkins Caufield & Byers.

Continue

EnVerv garners $15.4 mln

By Iris Dorbian — 2 years ago

EnVerv has secured $15.4 million in Series C financing. The investors were Cassiopeia Capital Partners, Cisco, UMC Capital, Benchmark Capital, NEA and Walden International. Headquartered in Milpitas, Calif., EnVerv is a fabless semiconductor company.

Continue

8×8 taps Continuum Capital’s Jacimovic for board of directors

By Iris Dorbian — 2 years ago

8×8 has named Vladimir Jacimovic to its board of directors. The appointment became effective March 20, 2014. Jacimovic is the founder and managing partner of Continuum Capital Partners. He was also a partner at New Enterprise Associates. Based in San Jose Calif. and the UK, 8×8 is a provider of cloud-based unified communications and virtual contact center solutions.

Continue

VC-backed Welltok buys mobile health firm Mindbloom

By Iris Dorbian — 2 years ago

Welltok, a health optimization company in Denver, has acquired Mindbloom. No financial terms were disclosed. Based in Seattle, Mindbloom is a mobile health firm. Welltok’s backers include NEA, IBM, Qualcomm Ventures, Emergence Capital Partners, InterWest Partners and Miramar Venture Partners.

Continue

Box adds Cisco chief technology and strategy officer to board of directors

By Angela Sormani — 2 years ago

Box has added Padmasree Warrior, chief technology and strategy officer for Cisco, to its board of directors. Headquartered in Los Altos, CA, Box is backed by Andreessen Horowitz, Bessemer Venture Partners, Draper Fisher Jurvetson, Emergence Capital Partners, General Atlantic, Meritech Capital Partners, NEA, Scale Venture Partners and U.S. Venture Partners as well as by strategic investors salesforce.com, SAP Ventures and Intel Ventures.

Continue

Box appoints healthcare advisors

By Angela Sormani — 2 years ago

Box has appointed Aneesh Chopra, the first chief technology officer of the US, and Glen Tullman, former CEO of Allscripts, to serve as special advisors for the company’s healthcare and life sciences practice. Headquartered in Los Altos, CA, Box is backed by Andreessen Horowitz, Bessemer Venture Partners, Draper Fisher Jurvetson, Emergence Capital Partners, General Atlantic, Meritech Capital Partners, NEA, Scale Venture Partners, and U.S. Venture Partners, as well as by strategic investors salesforce.com, SAP Ventures and Intel Ventures.

Continue

VC-backed TriVascular files for IPO

By Iris Dorbian — 2 years ago

TriVascular Technologies has filed for an IPO. The number of shares that will be offered as well as its pricing terms have yet to be set. The stock will trade on the NASDAQ under the ticker symbol “TRIV.” J.P. Morgan Securities and Credit Suisse Securities are the lead underwriters. Based in Santa Rosa, Calif., TriVascular Technologies is a provider of endovascular aortic repair solutions. Its backers include NEA, Delphi Ventures, MPM Capital, Kearny Venture Partners, Kaiser Permanente Ventures, Rock Springs Capital and Permal Asset Management.

Continue

Lumena attracts $45 mln in Series B funds

By Iris Dorbian — 2 years ago

Lumena Pharmaceuticals said Tuesday that it has closed $45 million in Series B financing. New Enterprise Associates led the round with participation from Adage Capital Management, RA Capital Management, Pappas Ventures, RiverVest Venture Partners and Alta Partners. Based in San Diego, Lumena is a biopharmaceutical company focused on rare cholestatic liver diseases and serious metabolic disorders.

Continue